Form 483

Eisai, Inc. Form 483, 2018-02-16

FDA issued a Form 483 to Eisai, Inc. on 2018-02-16 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Eisai, Inc. · Nutley, United States · Issued February 16, 2018

Overview

  • 3 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 Feb 2018
21 CFR 312.50

Ensuring compliance with plan and protocol

Cited by Nina Yang, Peter R Lenahan, Jean M Mulinde, Lauren C Iacono-Connors

16 Feb 2018
21 CFR 312.50

Ensuring compliance with plan and protocol

Cited by Nina Yang, Peter R Lenahan, Jean M Mulinde, Lauren C Iacono-Connors

16 Feb 2018
21 CFR 312.50

Ensuring compliance with plan and protocol

Cited by Nina Yang, Peter R Lenahan, Jean M Mulinde, Lauren C Iacono-Connors

Inspected site

EIEisai, Inc.Nutley, United States

Inspection team

LCLauren C Iacono-Connors

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere